drugset / Trial / NCT00866593
A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression
Phase 2/3
Completed
260 enrolled
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy and safety of Generic Escitalopram in the treatment of Chinese patients with depression compared with Innovator Escitalopram(Lexapro®) by evaluating the change of HAMD-17 total score from the baseline to week 8.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | — |
| Subject | Escitalopram | Small molecule | 20 mg | — |